Trial Profile
Intranasal atomized dexmedetomidine for sedation during third molar extraction.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Dexmedetomidine (Primary)
- Indications Dental pain; Sedation
- Focus Therapeutic Use
- 16 Dec 2015 New trial record